TGCT Observational Platform
Research type
Research Study
Full title
A disease registry for patients with tenosynovial giant cell tumors (TGCT), also known as pigmented villonodular synovitis (PVNS) and giant cell tumor of the tendon sheath (GCT-TS).
IRAS ID
209932
Contact name
Petra Laeis
Contact email
Sponsor organisation
Daiichi Sankyo Europe GmbH
Clinicaltrials.gov Identifier
not yet assigned, Clinicatrials.gov
Duration of Study in the UK
4 years, 0 months, 0 days
Research summary
Tenosynovial giant cell tumor (TGCT) is a rare type of cancer. The purpose of this study is to understand how patients with TGCT are diagnosed. treated and how their TGCT affects them. Patients with diffuse TGCT can be enrolled in this non-interventional prospective, observational disease registry. Specialised sites that regularly treat patients with TGCT will be enrolling patients for 2 years. Once entered patients will be followed up for a 2 year period and all data on their TGCT and treatment will be recorded.
REC name
London - Hampstead Research Ethics Committee
REC reference
17/LO/0251
Date of REC Opinion
14 Feb 2017
REC opinion
Favourable Opinion